FGF21 fibroblast growth factor 21
Selected indexed studies
- Fibroblast growth factor 21. (Differentiation, 2024) [PMID:38991938]
- Fibroblast growth factor 21 mitigates lupus nephritis progression via the FGF21/Irgm 1/NLRP3 inflammasome pathway. (Int Immunopharmacol, 2024) [PMID:38508095]
- Fibroblast growth factor 21 attenuates ventilator-induced lung injury by inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway. (Crit Care, 2023) [PMID:37218012]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Fibroblast growth factor 21. (2024) pubmed
- Fibroblast growth factor 21 mitigates lupus nephritis progression via the FGF21/Irgm 1/NLRP3 inflammasome pathway. (2024) pubmed
- Fibroblast growth factor 21 attenuates ventilator-induced lung injury by inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway. (2023) pubmed
- Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis. (2021) pubmed
- Lycopene alleviates age-related cognitive deficit via activating liver-brain fibroblast growth factor-21 signalling. (2024) pubmed
- Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction. (2021) pubmed
- Fibroblast growth factor 21 and bone homeostasis. (2023) pubmed
- Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine. (2023) pubmed
- Fibroblast growth factor 21 in heart failure. (2023) pubmed
- Impaired Fibroblast Growth Factor 21 (FGF21) Associated with Visceral Adiposity Leads to Insulin Resistance: The Core Defect in Diabetes Mellitus. (2025) pubmed